Disease Registries
| Home | | Pharmacovigilance |Chapter: Pharmacovigilance: Keynote Clinical Lessons from Pharmacovigilance
For many years it has been known that a number of disorders are at particularly high risk of being drug-induced.
DISEASE REGISTRIES
For
many years it has been known that a number of disorders are at particularly
high risk of being drug-induced. Calls have been made to commence registries
for such disorders, similar to the initiatives on aplas-tic anaemia following
the chloramphenicol problem or the registry of vaginal adenocarcinoma in young
women which proved so useful in identifying high dose stilboestrol in pregnancy
as the culprit. These calls have yet to lead to action and this seems to be an
opportunity missed. Such registries could prove to be valuable additions to the
pharmacovigilance arena as well as providing additional information about the
natural history of the selected key disorders in the twenty-first century.
Related Topics
